The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Janus Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about Janus Kinase Inhibitors.
Olatoyosi Odenike
Connection Strength
0.791
Janus Kinase Inhibitors
  1. The Next Generation of JAK Inhibitors: an Update on Fedratinib, Momelotonib, and Pacritinib. Curr Hematol Malig Rep. 2020 12; 15(6):409-418.
    View in: PubMed
    Score: 0.733
  2. Methodological challenges in the development of endpoints for myelofibrosis clinical trials. Lancet Haematol. 2024 May; 11(5):e383-e389.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.